Y-Intercept (HK)’s Elevance Health ELV Stock Holding History

Y-Intercept (HK)’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.75M	Sell	7,077 -42,621	-86%	-$17M	0.06%	468
2026 Q2	$19.2M	Buy	49,698 +21,198	+74%	+$7.86M	0.38%	28
2026 Q1	$8.34M	Buy	+28,500	New	+$9.37M	0.16%	149
2025 Q4	–	Sell	-5,522	Closed	-$1.78M	–	1665
2025 Q3	$1.78M	Sell	5,522 -18,025	-77%	-$5.61M	0.04%	679
2025 Q2	$9.16M	Buy	23,547 +22,745	+2,836%	+$9.15M	0.22%	83
2025 Q1	$349K	Sell	802 -12,339	-94%	-$4.95M	0.02%	851
2024 Q4	$4.85M	Buy	+13,141	New	+$5.5M	0.32%	54
2024 Q3	–	Sell	-5,085	Closed	-$2.76M	–	1444
2024 Q2	$2.76M	Buy	5,085 +207	+4%	+$109K	0.15%	165
2024 Q1	$2.53M	Buy	4,878 +2,117	+77%	+$1.05M	0.19%	123
2023 Q4	$1.3M	Sell	2,761 -1,947	-41%	-$900K	0.12%	227
2023 Q3	$2.05M	Sell	4,708 -791	-14%	-$359K	0.2%	134
2023 Q2	$2.44M	Buy	+5,499	New	+$2.54M	0.26%	82
2022 Q3	–	Sell	-3,882	Closed	-$1.87M	–	1055
2022 Q2	$1.87M	Buy	+3,882	New	+$1.92M	0.25%	95
2021 Q3	–	Sell	-1,024	Closed	-$391K	–	715
2021 Q2	$391K	Buy	+1,024	New	+$391K	0.1%	332

Other funds holding ELV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Maj Invest Holding A/S Copenhagen K, Denmark $2.26B AUM 22.4% 1-Year Est. Return

Marathon Asset Management (UK) London, United Kingdom $2.2B AUM 25.78% 1-Year Est. Return

Y-Intercept (HK)'s ELV Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Elevance Health (ELV) stake by 86% in Q3 2026, selling an estimated $17M and leaving 7,077 shares worth $2.75M. The position accounts for 0.06% of the portfolio, ranked #468.

Y-Intercept (HK) first reported a position in ELV in Q2 2021 and has held it in 14 quarters since. The position peaked at $19.2M in Q2 2026. 555 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

Y-Intercept (HK) held 7,077 shares of Elevance Health worth $2.75M as of Q3 2026.
Y-Intercept (HK) sold 42,621 Elevance Health shares in Q3 2026, an estimated $17M.
Elevance Health made up 0.06% of Y-Intercept (HK)'s portfolio in Q3 2026, its #468 holding.
Y-Intercept (HK) first reported a position in Elevance Health in Q2 2021 and has held it in 14 quarters since.
Y-Intercept (HK)'s Elevance Health position peaked at $19.2M in Q2 2026.
555 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.